| abstract |
The present invention relates to pyridine derivatives or formula (I) where A is a 4-, 5- or 6-membered saturated ring; R1, R2 and R3 are organic groups as specified in the application. Processes for their preparation, pharmaceutical compositions containing them and their use in therapy, in particular in the modulation of autoimmune disease are also described. |